Inventor
EARY CHARLES TODD
US14 patents
⚠️ This page may combine multiple inventors who share the name “EARY CHARLES TODD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LOXO ONCOLOGY INC
9 patentsUS10786489B2Sep 29, 2020
Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrile
LOXO ONCOLOGY INC9 citations83
US10745419B2Aug 18, 2020
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
LOXO ONCOLOGY INC2 citations70
US12138250B2Nov 12, 2024
Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
LOXO ONCOLOGY INC0 citations62
US12102621B2Oct 1, 2024
Formulations of 6-(2-hydroxy-methylpropoxy-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
LOXO ONCOLOGY INC0 citations62
US11963950B2Apr 23, 2024
Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
LOXO ONCOLOGY INC0 citations62
US11807651B2Nov 7, 2023
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
LOXO ONCOLOGY INC0 citations59
US11098064B2Aug 24, 2021
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile
LOXO ONCOLOGY INC1 citations59
US12268666B2Apr 8, 2025
Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide
LOXO ONCOLOGY INC0 citations52
US12109193B2Oct 8, 2024
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide
LOXO ONCOLOGY INC0 citations52
ARRAY BIOPHARMA INC
4 patentsUS8044083B2Oct 25, 2011
Kinase inhibitors and methods of use thereof
ARRAY BIOPHARMA INC5 citations71
US11091486B2Aug 17, 2021
Process for the preparation of pyrazolo[1,5-a]pyrimidines and salts thereof
ARRAY BIOPHARMA INC0 citations61
US8039639B2Oct 18, 2011
Kinase inhibitors and methods of use thereof
ARRAY BIOPHARMA INC4 citations58
US11214571B2Jan 4, 2022
Process for the preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and salts thereof
ARRAY BIOPHARMA INC0 citations50